ArticlePDF Available

Gulf War illness - better, worse, or just the same? A cohort study

Authors:

Abstract and Figures

Firstly, to describe changes in the health of Gulf war veterans studied in a previous occupational cohort study and to compare outcome with comparable non-deployed military personnel. Secondly, to determine whether differences in prevalence between Gulf veterans and controls at follow up can be explained by greater persistence or greater incidence of disorders. Occupational cohort study in the form of a postal survey. Military personnel who served in the 1991 Persian Gulf war; personnel who served on peacekeeping duties to Bosnia; military personnel who were deployed elsewhere ("Era" controls). All participants had responded to a previous survey. United Kingdom. Self reported fatigue measured on the Chalder fatigue scale; psychological distress measured on the general health questionnaire, physical functioning and health perception on the SF-36; and a count of physical symptoms. Gulf war veterans experienced a modest reduction in prevalence of fatigue (48.8% at stage 1, 43.4% at stage 2) and psychological distress (40.0% stage 1, 37.1% stage 2) but a slight worsening of physical functioning on the SF-36 (90.3 stage 1, 88.7 stage 2). Compared with the other cohorts Gulf veterans continued to experience poorer health on all outcomes, although physical functioning also declined in Bosnia veterans. Era controls showed both lower incidence of fatigue than Gulf veterans, and both comparison groups showed less persistence of fatigue compared with Gulf veterans. Gulf war veterans remain a group with many symptoms of ill health. The excess of illness at follow up is explained by both higher incidence and greater persistence of symptoms.
Content may be subject to copyright.
Papers
Gulf war illness—better, worse, or just the same? A cohort study
M Hotopf, Anthony S David, Lisa Hull, Vasilis Nikalaou, Catherine Unwin, Simon Wessely
Abstract
Objectives Firstly, to describe changes in the health of Gulf war
veterans studied in a previous occupational cohort study and to
compare outcome with comparable non-deployed military
personnel. Secondly, to determine whether differences in
prevalence between Gulf veterans and controls at follow up can
be explained by greater persistence or greater incidence of
disorders.
Design Occupational cohort study in the form of a postal
survey.
Participants Military personnel who served in the 1991 Persian
Gulf war; personnel who served on peacekeeping duties to
Bosnia; military personnel who were deployed elsewhere (“Era”
controls). All participants had responded to a previous survey.
Setting United Kingdom.
Main outcome measures Self repor ted fatigue measured on
the Chalder fatigue scale; psychological distress measured on
the general health questionnaire, physical functioning and
health perception on the SF-36; and a count of physical
symptoms.
Results Gulf war veterans experienced a modest reduction in
prevalence of fatigue (48.8% at stage 1, 43.4% at stage 2) and
psychological distress (40.0% stage 1, 37.1% stage 2) but a slight
worsening of physical functioning on the SF-36 (90.3 stage 1,
88.7 stage 2). Compared with the other cohorts Gulf veterans
continued to experience poorer health on all outcomes,
although physical functioning also declined in Bosnia veterans.
Era controls showed both lower incidence of fatigue than Gulf
veterans, and both comparison groups showed less persistence
of fatigue compared with Gulf veterans.
Conclusions Gulf war veterans remain a group with many
symptoms of ill health. The excess of illness at follow up is
explained by both higher incidence and greater persistence of
symptoms.
Introduction
Consensus exists that service in the 1991 Persian Gulf war
resulted in increased symptomatic ill health among those
deployed.
1–8
We know of no studies on the prognosis of
symptoms among Gulf war veterans. In 1997 we studied a large
random sample of members of the armed forces who served in
the 1991 Gulf war,
1
including those who had left the services. We
compared the “Gulf cohort” with two military control cohorts.
This study assesses the outcomes of these cohorts four years
later. Our two main aims were, firstly, to compare the prevalence
of various health outcomes over time and between cohorts, and,
secondly, to determine rates of incidence and remission for clini-
cally important fatigue and psychological distress after adjusting
for potential confounders.
Method
Participants
Our original study consisted of three groups: personnel who
served in the Persian Gulf war between 1 September 1990 and
30 June 1991 (the Gulf cohort); personnel who served on UN
peacekeeping duties in Bosnia between 1 April 1992 and 6 Feb-
ruary 1997 (the Bosnia cohort); and personnel who were serving
in the armed forces on 1 January 1991 but who were not
deployed to the Gulf (the “Era” cohort).
1
We took a random
sample of all Gulf veterans, with oversampling of women.
Sampling of the other two cohorts was frequency matched in
terms of sex, age, reservist status, officer status, service (Royal
Navy, Army, or Royal Air Force), and a measure of fitness.
Of 8196 participants who responded to the first survey 503
refused permission for future contact and 449 failed to complete
the relevant section of the questionnaire. We used random strati-
fied sampling to select respondents from stage 1 into the present
study. All women were selected. We stratified the sampling on the
severity of fatigue at stage 1. The selection process included all
male veterans with a fatigue score greater than 8 (511 Gulf, 115
Bosnia, and 120 Era); for Gulf, a 50% sample of veterans with
fatigue scores of 4-8 (484 veterans), along with all those in Bosnia
(n = 333) and Era (n = 364) who scored in this range; and an
approximately one in eight sample of veterans with fatigue
scores less than 4 in order to represent asymptomatic individuals
(n = 250 in each group).
Mailing method
We used three mailings. To trace non-responders we used the
NHS central registry to obtain health authority ciphers and cur-
rent addresses. We used the online electoral registry “Cameo” to
check addresses. Service pension and discharge sources supplied
updated addresses. We sent the second and third mailings via
commanding officers, asking for their help in disseminating the
questionnaires on our behalf. Following an agreement with the
War Pensions Agency, the UK Depar tment of Social Security
sent two further mailings. In order to comply with data
protection regulation, we were not informed which addresses the
Department of Social Security had on their records.
Questionnaire and outcomes
The questionnaire included a fatigue scale
9
; the 12 item general
health questionnaire (a screening questionnaire for common
mental disorders)
10
; the SF-36 instrument for physical health and
functional capacity
11–13
; and a list of 50 common symptoms. We
defined cases of fatigue as having a score on the fatigue scale of
greater than 3 and cases of psychological distress as having a
score greater than 2 on the general health questionnaire. We
defined cases of “stress reaction” from a checklist of symptoms
described in previous work.
1
Editor ial by Clauw and p 1373
page 1 of 4BMJ VOLUME 327 13 DECEMBER 2003 bmj.com
Statistical analyses
Response bias—We defined four groups
responders, “refus-
ers, “returns to sender” (where questionnaires were returned to
us), and “no information” (where no reply was forthcoming). We
compared the frequency of these four outcomes by cohort. We
determined whether response bias was present by comparing
demographic variables and stage 1 health outcomes across
cohorts, using Scheffé’s test.
14
Follow up health outcomes
To take account of the sampling
strategy all analyses used sampling weights and robust standard
errors by using the appropriate commands in Stata (StataCorp,
College Station, TX). We calculated the prevalence of binary out-
come variables and present these in relation to baseline scores.
For binary outcomes we present the matched odds ratio, which is
the proportion of incident cases to recovered cases for each out-
come. For continuous outcomes we present stage 1 and 2 scores
and mean differences with 95% confidence intervals.
Results
Response rates
The response rate for those eligible to receive a questionnaire
was 71.6% (table 1). The response rate was higher in the Gulf
cohort than in the other two cohorts (P = 0.03). A similar pattern
emerged in terms of types of non-respondents in Gulf and
Bosnia, but the Era group had a higher proportion of refusers
than the other two cohorts. Response rates were lower in men,
younger participants, and those who were unmarried. Non-
responders rated their health as poorer at stage 1 for physical
disability and general health perception but were less likely to
have been cases on the general health questionnaire.
Table 2 shows the sociodemographic characteristics of the
participants and indicates that Gulf and Era were broadly similar.
The Bosnia group were younger, less likely to be married, more
likely to have remained in service, and only from the Army.
Table 3 shows the prevalence of categorical outcomes at
stages 1 and 2. We report the prevalence of stage 1 outcomes
within the sample studied at stage 2, not for the entire cohort
hence the prevalence figures we report for stage 1 are similar, but
not identical to, those shown in our previous paper.
1
Table 3
shows that Gulf had higher rates of the disorders under study
than the other two cohorts, and this difference is maintained
between stages 1 and 2. For Gulf we found a modest reduction in
the prevalence of fatigue, post-traumatic stress reaction, general
health questionnaire cases, and self reported “Gulf war
syndrome. For Bosnia and Era we found no changes other than
an increase in the prevalence of post-traumatic stress reaction in
the Era group, which was not significant (P > 0.05).
Table 4 shows the scores on continuous measures at each time
point for the three cohorts. The Gulf cohort was less healthy than
the other two cohorts at both stages. A decline in physical
functioning affected each of the three cohorts (non-significant for
Era). Health perception declined for both Bosnia and Era but not
Table 1 Characteristics of responders and non-responders in a cohort study among Gulf war veterans. Values are numbers (percentages) unless otherwise
indicated
Responders v all non-responders Responders v type of non-responder
Responders
(n=2370)
All non-responders
(n=935) Statistic
Refuser
(n=246)
No information
(n=433)
Return to sender
(n=256) Statistic
Cohort:
Gulf 1089 (74.0)
1
383 (26.0)
2
=6.8 (df=2) (P=0.03)
88 (6.0)
2
191 (13.0)
2
104 (7.0)
1
2
=25.4 (df=6) P<0.001
Bosnia 638 (70.2) 271 (29.8) 59 (6.5) 133 (14.6) 79 (8.7)
Era 643 (69.6) 281 (30.4) 99 (10.7) 109 (11.8) 73 (7.9)
Male sex (%) 1873 (79.0)
3
791 (84.6)
2
=13.3 (df=1) P<0.001 209 (85.0) 374 (86.4)
3
208 (81.3)
2
=16.0 (df=3) P=0.001
Age in years in 2002 (SD) 37.7 (7.4)
a
36.3 (6.9) I=4.8 P<0.0001 37.9 (7.3)
b
35.6 (6.9)
a, b
36.2 (6.4) F
3
, 3301=13.1
P<0.0001
Commissioned officers 416 (17.6)
4
90 (9.6)
2
=32.5 (df=1) P<0.001 30 (12.2)
6
26 (6.0)
4, 5, 6
34 (13.3)
5
2
=40.8 (df=3) P<0.001
Marital status:
Married or cohabiting 1640 (69.9) 596 (64.6)
2
=9.1 (df=2) P=0.01
170 (70.0) 268 (63.1) 158 (62.0)
2
=14.6 (df=6) P=0.02
Never married 481 (20.5) 218 (23.6) 52 (21.4) 102 (24.0) 64 (25.1)
Widowed, separated, or divorced 224 (9.6) 109 (11.8) 21 (8.6) 55 (12.9) 33 (12.9)
Still serving 1444 (60.9)
7
541 (57.9)
2
=2.6 (df=1) P=0.1 141 (57.3) 229 (52.9)
7, 8
171 (66.8)
8
2
=15.6 (df=3) P=0.001
SF-36 physical functioning (SD) 89.2 (18.3)
c
86.9 (20.9) t=3.1
P=0.002
83.9
(17.4)
cd
86.9 (20.8) 89.8 (17.4)
d
F 3, 3225=7.00
P<0.0001
SF-36 health perception (SD) 64.7 (26.0)
e
62.1 (27.2) t=2.6
P=0.01
61.8
(27.5)
60.2 (28.3)
e
65.5 (24.8) F
3
, 3297=4.4
P=0.004
General health questionnaire case 1193 (51.1) 432 (47.3)
2
=3.8 (df=1) P=0.05 115 (47.5) 197 (47.0) 120 (47.6)
2
=3.8 (df=3) P=0.3
Fatigue case 832 (35.3) 323 (34.7)
2
=0.1 (df=1) P=0.7 246 (37.4) 133 (30.9) 98 (37.4)
2
=5.3 (df=3) P=0.15
a, b, c, d, e
: Scheffé test
14
, P<0.01;
1-8
: specific contrasts on
2
, P<0.01.
Table 2 Characteristics of the three cohorts. Values are numbers (percentages) unless otherwise indicated
Stage 1 variables Gulf (n=1089) Bosnia (n=638) Era (n=643)
Men 918 (84.5) 484 (76.6) 502 (78.2)
Mean age (SD) 39.2 (6.9) 33.7 (6.7) 39.8 (7.5)
Service:
Royal Navy 80 (7.4) 56 (8.7)
Army 881 (81.0) 632 (100)* 470 (73.2)
Royal Air Force 127 (11.7) 116 (18.1)
Officers 166 (15.8) 123 (19.7) 142 (24.1)
Married 809 (74.8) 355 (57.1) 633 (74.4)
Still serving at stage 1 583 (54.7) 558 (88.4) 319 (54.1)
*Bosnia was selected only from Army.
Papers
page 2 of 4 BMJ VOLUME 327 13 DECEMBER 2003 bmj.com
for Gulf. The Gulf v eterans showed a modest reduction in fatigue
scores and non-significant but small reductions in general health
questionnaire scores and total symptoms. The other tw o cohorts
show ed a general tendency to experience more symptoms ov er
time; six changes were significant (P < 0.05).
Because it was possible that differences in prevalence
between cohorts could have been explained by either higher
incidence, or greater persistence, of symptoms this was explored
in table 5. The incidence risk for fatigue and general health ques-
tionnaire caseness was lower in Era than the other two cohorts.
Controlling for stage 1 sociodemographic variables reduced the
differences, but the Era group remained less likely to experience
new fatigue than the Gulf group. The Gulf group were more
likely to experience persistent fatigue compared with the Era
and Bosnia cohorts, an effect that remained significant after con-
trolling for potential confounders (P = 0.009).
Discussion
Main findings
Gulf war v eterans continue to experience symptoms that are con-
siderably worse than would be expected in an equivalent cohort of
military personnel. However, Gulf war veterans are not deteriorat-
ing and do not have a higher incidence of new illnesses.
Our study had two main aims. Firstly , w e wanted to describe
the outcome of Gulf war veterans three to four years after we first
surv eyed them. Our results show a disappointing stability in the
prevalence of the main disorders we studied. Although the preva-
Table 3 Prevalence of categorical outcomes in the three cohorts. Values are percentages (95% confidence intervals) unless otherwise indicated
Gulf Bosnia Era
Stage 1 Stage 2
Ratio* (new
cases/recovered
cases) Stage 1 Stage 2
Ratio* (new
cases/
recovered
cases) Stage 1 Stage 2
Ratio* (new
cases/recovered
cases)
Fatigue cases 48.8
(45.4 to 52.2)
43.4
(39.9 to 46.8)
0.65
(0.45 to 0.85)
29.0
(25.6 to 32.4)
32.7
(28.6 to 36.8)
1.21
(0.83 to 1.59)
22.8
(20.0 to 25.6)
22.0
(18.6 to 25.4)
0.91
(0.56-1.26)
Post-traumatic
stress reaction
cases
12.4
(10.7 to 14.2)
10.8
(9.1 to 12.5)
0.73
(0.47 to 0.99)
5.7
(4.0 to 7.4)
6.0
(4.2 to 7.8)
1.07
(0.49 to 1.65)
4.0
(2.6 to 5.3)
6.6
(4.8 to 8.4)
2.45
(0.88-4.02)
General health
questionnaire
cases
40.0
(36.8 to 43.2)
37.1
(33.8 to 40.4)
0.79
(0.59 to 1.00)
29.2
(25.5 to 32.9)
31.5
(27.4 to 35.6)
1.25
(0.84 to 1.67)
25.3
(21.7 to 28.9)
23.8
(20.1 to 27.6)
0.88
(0.56-1.20)
Self reported
Gulf war
syndrome
18.6
(16.2 to 21.1)
15.8
(13.3 to 18.2)
0.58
(0.25 to 0.90)
All prevalence estimates are weighted for sampling.
*Values of <1 indicate declining prevalence. Ratios are weighted for sampling.
Table 4 Scores (95% confidence intervals) for continuous measures by cohort and stage
Gulf Bosnia Era
Stage 1 Stage 2 Difference Stage 1 Stage 2 Difference Stage 1 Stage 2 Difference
SF-36* physical
function
90.3
(88.3 to 91.3)
88.7
(87.6 to 89.9)
1.6
(2.5 to 0.7)
95.4
(94.4 to 96.4)
92.9
(91.6 to 94.1)
2.6
(3.8 to 1.3)
92.1
(90.6 to 93.6)
90.8
(89.2 to 92.3)
1.3
(2.7 to 0.1)
SF-36* health
perception
65.8
(64.1 to 67.5)
65.9
(64.2 to 67.6)
0.1
(1.2 to 1.4)
76.2
(74.4 to 77.9)
72.9
(71.0 to 74.8)
3.3
(5.1 to 1.6)
76.8
(75.0 to 78.6)
74.4
(72.4 to 76.4)
2.4
(4.2 to 0.6)
General health
questionnaire
14.5
(14.1 to 14.9)
14.2
(13.8 to 14.5)
0.3
(0.1, 0.6)
13.1
(12.7 to 13.6)
13.2
(12.7 to 13.7)
0.1
(0.4 to 0.6)
12.4
(12.0 to 12.8)
12.9
(12.5 to 13.3)
0.5
(0.05 to 1.0)
Fatigue 17.8
(17.4 to 18.1)
16.9
(16.5 to 17.2)
0.9
(1.2 to 0.6)
15.6
(15.2 to 16.0)
15.3
(14.9 to 15.7)
0.3
(0.7 to 0.2)
14.7
(14.3 to 15.0)
14.9
(14.5 to 15.3)
0.2
(0.2 to 0.6)
Total symptoms 11.0
(10.4 to 11.6)
10.7
(10.1 to 11.3)
0.3
(0.8 to 0.1)
6.2
(5.6 to 6.8)
7.9
(7.3 to 8.5)
1.7
(1.2 to 2.3)
5.3
(4.8 to 5.8)
6.4
(5.8 to 7.0)
1.1
(0.6 to 1.6)
All scores are weighted for sampling.
*SF-36 scales range from 0-100, with higher scores indicating better health.
For SF-36 scores, negative differences in mean indicate a worsening in health. For other scales, negative scores indicate an improvement in health.
Table 5 Incidence and persistence of outcomes. Values are presented with 95% confidence intervals
Cohort
Incidence Persistence
Risk Crude odds ratio Corrected odds ratio* Risk Crude odds ratio Corrected odds ratio*
General health questionnaire cases:
Gulf 20.2 (16.4 to 24.0) 1.0 1.0 61.8 (57.3 to 66.3) 1.0 1.0
Bosnia 21.2 (16.7 to 25.8) 1.1 (0.7 to 1.5) 0.9 (0.6 to 1.4) 58.9 (51.9 to 65.8) 0.9 (0.6 to 1.1) 1.1 (0.7 to 1.6)
Era 15.4 (11.4 to 19.4) 0.7 (0.5 to 1.1) 0.7 (0.5 to 1.1) 48.4 (41.0 to 55.9) 0.8 (0.6 to 1.1) 0.6 (0.4 to 0.8)
Fatigue cases:
Gulf 18.8 (14.4 to 23.1) 1.0 1.0 69.7 (66.4 to 73.0) 1.0 1.0
Bosnia 19.8 (15.1 to 24.4) 1.1 (0.7 to 1.6) 0.9 (0.6 to 1.5) 59.9 (54.2 to 65.6) 0.6 (0.5 to 0.9) 0.7 (0.5 to 1.0)
Era 11.2 (7.5 to 15.0) 0.6 (0.3 to 0.9) 0.5 (0.3 to 0.9) 58.2 (53.1 to 63.4) 0.6 (0.5 to 0.8) 0.7 (0.5 to 0.9)
Post-traumatic stress reaction cases:
Gulf 5.0 (3.6 to 6.4) 1.0 1.0 51.8 (44.8 to 58.9) 1.0 1.0
Bosnia 4.0 (2.5 to 5.5) 0.8 (0.5 to 1.3) 0.8 (0.4 to 1.5) 38.9 (24.3 to 53.3) 0.6 (0.3 to 1.2) 0.8 (0.4 to 1.8)
Era 4.6 (3.0 to 6.2) 0.9 (0.6 to 1.5) 0.9 (0.5 to 1.5) 54.8 (37.8 to 71.9) 1.1 (0.5 to 2.4) 1.2 (0.6 to 2.7)
*Controlled for demographic variables (age, sex, rank, marital status).
Paper s
page 3 of 4BMJ VOLUME 327 13 DECEMBER 2003 bmj.com
lence of the symptom based disorders lessened for Gulf veterans,
physical functioning and health perception measured on the
SF-36 barely changed. The reduced physical functioning may have
been due to increasing age. The two comparison groups had some
worsening in health on the SF-36 scales and more physical symp-
toms. This implies that some w orsening of these health outcomes
is expected ov er time, presumably due to advancing age. At each
wave the prevalence between Gulf and the two comparison groups
differs, and, although the gap narrowed slightly, the Gulf v eterans
continued to experience poorer health on all measures.
Our second aim was to examine whether the raised prevalence
in Gulf veterans was explained by a greater incidence of disorders
or more persistence. No clear pattern emerged. We found some
evidence that the incidence of fatigue and caseness on the general
health questionnaire was higher in the two deployed groups
(Bosnia and Gulf) than in Era but that the difference for the
general health questionnaire was explained by confounding. F or
fatigue we found evidence that the Gulf group continued to have
greater incidence than the Era group , and this was not explained
by confounding. For persistence we found a strong trend for
Gulf veterans with fatigue to be more likely to remain fatigued at
follow up.
Limitations of the study
We achieved a follow up rate of just over 70%, which leaves room
for bias. Because follow up rates were worse in participants with
poorer health at stage 1 we have probably slightly underesti-
mated the prevalence of the disorders under study. The effect of
this bias seems to have been similar across cohorts, which makes
it unlikely that the non-response bias would have led to the Gulf
group having still higher than expected prevalence figures at
stage 1. We believe that the missing values are unlikely to have
changed the main findings of this study. We measured health on
a range of self report items, which are open to reporting biases.
Implications
The nature of Gulf war illness remains ambiguous. If the illness
represented the prodrome of a known disease (such as a neuro-
logical disorder), even with the passage of time, this has yet to
declare itself.
15 16
We think that the non-specific increase in
symptoms reported by our and other studies is likely to remain
poorly understood in terms of conventional biomedical diseases.
This study did not have the statistical power to assess mortality in
Gulf war veterans, and this was not our aim. Other studies in the
United Kingdom and the United States, however, have failed to
find higher than expected death rates.
17 18
Finally, as time passes
it becomes increasingly difficult to find causes of illnesses in vet-
erans of the 1990-1 Gulf war. We suspect that different
psychosocial, military and environmental risk factors may deter-
mine onset and recovery, and this is the topic of future research.
We thank Nick Blatchley and Simon Satchell from the Gulf Veterans Illness
Unit of the Ministry of Defence for assistance in tracking participants,
Michael Dewey for statistical advice, and the participants for their patience
in once again completing lengthy questionnaires.
Contributors: MH, ASD, and SW designed the study. CU snf LH were
responsible for data collection under the supervision of SW, ASD, and MH.
MH and VN ptrformed the statistical analyses. MH wrote the paper and is
the guarantor. All authors provided comments.
Funding: US Department of Defense, UK Medical Research Council.
Competing interests: None declared.
Ethical approval: The study received approval from the relevant research
ethics committees.
1 Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L, et al. Health of UK service-
men who served in the Persian Gulf war. Lancet 1999;353:169-78.
2 Cherry N, Creed F, Silman A, Dunn G, Baxter D, Smedley J, et al. Health and exposures
of United Kingdom Gulf war veterans. Part I: The pattern and extent of ill health. Occup
Environ Med 2001;58:291-8.
3 Fukuda K, Nisenbaum R, Stewart G. Chronic multisymptom illness affecting air force
veterans of the gulf war. JAMA 1998;2809:981-8.
4 Proctor SP, Heeren T, White RF, Wolfe J, Borgos MS, Davis JD, et al. Health status of
Persian Gulf war veterans: self-reported symptoms, environmental exposures and the
effect of stress. Int J Epidemiol 1998;27:1000-10.
5 Gray GC, Kaiser KS, Hawksworth AW, Hall FW, Barrett-Connor E. Increased postwar
symptoms and psychological morbidity among U.S. Navy Gulf war veterans. Am J Trop
Med Hygiene 1999;60:758-66.
6 Gray GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM. Self-reported symptoms and
medical conditions among 11,868 Gulf war-era veterans: the Seabee health study. Am J
Epidemiol 2002;155(11):1033-44.
7 Steele L. Prevalence and patterns of Gulf war illness in Kansas veterans: association of
symptoms with characteristics of person, place, and time of military service. Am J Epide-
miol 2000;152:992-1002.
8 Anon. Health study of Canadian forces personnel involved in the 1991 conflict in the Persian
Gulf. Ottawa: Goss Gilroy, 1998.
9 Chalder T, Berelowitz C, Pawlikowska T. Development of a fatigue scale. J Psychosom Res
1993;37:147-54.
10 Goldberg D, Williams P. A users’ guide to the general health questionnaire. Windsor: NFER-
Nelson, 1988.
11 McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-form health
survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across
diverse patient groups. Med Care 1994;32:40-66.
12 McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-item short-form health survey
(SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental
health constructs. Med Care 1993;31:247-63.
13 Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I.
Conceptual framework and item selection. Med Care 1992;30:473-83.
14 Scheffé H. A method for judging all contrasts in the analysis of variance. Biometrika
1953;40:87-104.
15 Sharief M, Pridden J, Delamont R, Unwin C, Rose M, David A, et al. Neurophysiological
evaluation of neuromuscular symptoms in UK Gulf war veterans. A controlled study.
Neurology 2002;59:1518-825.
16 David A, Farrin L, Hull L, Unwin C, Wessely S, Wykes T. Cognitive functioning and dis-
turbance of mood in UK veterans of the Persian Gulf war: a comparative study. Psychol
Med 2002;32:1357-70.
17 MacFarlane GJ, Thomas E, Cherry N. Mortality among UK Gulf war veterans. Lancet
2000;356:17-21.
18 Kang H, Bullman T. Mortality among U.S. veterans of the Persian Gulf war. N Engl J Med
1996;335:1498-504.
(Accepted 14 October)
bmj.com 2003;327:1370
Gulf War Illnesses Research Unit, Department of Psychological Medicine, Guy’s,
King’s, and St Thomas’s School of Medicine, London SE5 8AZ
Matthew Hotopf reader
Anthony S David professor
Lisa Hull research assistant
Vasilis Nikalaou statistician
Catherine Unwin study coordinator
Simon Wessely professor
Correspondence to: M Hotopf
m.hotopf@iop.kcl.ac.uk
What is already known on this topic
Veterans of the 1990-1 Gulf war experience poorer health
on most subjective outcomes than non-deployed military
personnel
No satisfactory follow up studies have assessed outcome of
veterans of the Gulf war over more than one wave of data
collection, so it is unclear whether veterans are getting
worse, staying the same, or getting better
What this study adds
Gulf war veterans still have considerably poorer subjective
health than appropriate military controls
The health of Gulf war veterans has improved, but this
improvement is relatively minor
For comparison groups there has been a worsening of
health on some outcomes, which is probably due to ageing
The health gap between Gulf war veterans and comparison
groups has therefore narrowed slightly
Papers
page 4 of 4 BMJ VOLUME 327 13 DECEMBER 2003 bmj.com
... For example, a significant interaction between prior PB use and butyrylcholinesterase (BChE) genotype for GWI severity has been reported (Steele, Lockridge, Gerkovich, Cook, & Sastre, 2015). Similarly, low activity of the enzyme paraoxonase1 (PON1) that metabolizes OPs has also been attributed to GWI susceptibility in veterans (Haley, Billecke, & La Du, 1999;Hotopf et al., 2003;Mackness, Durrington, & Mackness, 2000). ...
... However, when the duration of exposure to this GW chemical combination was increased to 60 days, a delayed pain-like syndrome was noted 12 weeks post exposure (Nutter et al., 2015). This is an important point that adds to the translational ability of this model since it is reported that the majority of veterans began experiencing pain symptoms following their return stateside from GW deployment (Hotopf et al., 2003;Kroenke, Koslowe, & Roy, 1998). Thus, the delayed emergence of pain-like behavior in this model is consistent with the GW experience. ...
Article
Gulf War Illness (GWI) is a chronic multisymptomatic disorder that afflicts over 1/3rd of the 1991 GW veterans. It spans multiple bodily systems and presents itself as a syndrome exhibiting diverse symptoms including fatigue, depression, mood, and memory and concentration deficits, musculoskeletal pain and gastrointestinal distress in GW veterans. The etiology of GWI is complex and many factors, including chemical, physiological, and environmental stressors present in the GW arena, have been implicated for its development. It has been over 30 years since the end of the GW but, GWI has been persistent in suffering veterans who are also dealing with paucity of effective treatments. The multifactorial aspect of GWI along with genetic heterogeneity and lack of available data surrounding war-time exposures have proved to be challenging in developing pre-clinical models of GWI. Despite this, over a dozen GWI animal models exist in the literature. In this article, following a brief discussion of GW history, GWI definitions, and probable causes for its pathogenesis, we will expand upon various experimental models used in GWI laboratory research. These animal models will be discussed in the context of their attempts at mimicking GW-related exposures with regards to the variations in chemical combinations, doses, and frequency of exposures. We will discuss their advantages and limitations in modeling GWI followed by a discussion of behavioral and molecular findings in these models. The mechanistic data obtained from these preclinical studies have offered multiple molecular pathways including chronic inflammation, mitochondrial dysfunction, oxidative stress, lipid disturbances, calcium homeostatic alterations, changes in gut microbiota, and epigenetic modifications, amongst others for explaining GWI development and its persistence. Finally, these findings have also informed us on novel druggable targets in GWI. While, it has been difficult to conceive a single pre-clinical model that could express all the GWI signs and exhibit biological complexity reflective of the clinical presentation in GWI, animal models have been critical for identifying molecular underpinnings of GWI and evaluating treatment strategies for GWI.
... Results from these studies indicate that the higher burden of symptoms among Gulf War veterans relative to nondeployed reference groups persists over time. [11][12][13][14][15] However, inconsistent findings were found regarding rates of symptom change, with some studies finding no differences compared with nondeployed reference groups 14,15 while others observed more rapidly increasing symptom prevalences among Gulf War veterans. 11 Understanding ...
... Results from these studies indicate that the higher burden of symptoms among Gulf War veterans relative to nondeployed reference groups persists over time. [11][12][13][14][15] However, inconsistent findings were found regarding rates of symptom change, with some studies finding no differences compared with nondeployed reference groups 14,15 while others observed more rapidly increasing symptom prevalences among Gulf War veterans. 11 Understanding ...
Article
Full-text available
Objective: Chronic multisymptom illness/Gulf War illness (CMI/GWI) is the defining illness of the 1990-1991 Gulf War. However, few studies have examined changes over time in CMI/GWI prevalence. Methods: Prevalence of CMI/GWI over time was compared between three groups of military personnel (9,110 Gulf War veterans, 36,019 era personnel, 31,446 non-era personnel) enrolled in the Millennium Cohort Study. Post hoc analyses were conducted among participants with no reported mental and physical health conditions (N = 30,093). Results: CMI/GWI prevalence increased substantially over the study period among all groups. Gulf War veterans had the highest prevalence of CMI/GWI across the study period. This finding persisted after excluding participants with mental and physical health conditions. Conclusions: Gulf War veterans' increased risk of CMI/GWI persisted across the study period, highlighting the continued importance of screening and improving treatment options among this population.
... Still, the validated constructs of depression, PTSD, sleep disturbance, and pain offer specific targets for potential intervention that may improve veterans' overall HRQOL perceptions. Indeed, these subjective measures of health status have long been identified as adversely afflicting Gulf War era veterans [9]. Finally, scientists have long been investigating potential root causes (e.g., oil well fires, pyridostigmine bromide pills, sarin gas, vaccines, infectious diseases, etc.) of GWI [63,64], but consensus has not yet been reached. ...
Article
Full-text available
This study examines how health-related quality of life (HRQOL) and related indices vary by Gulf War illness (GWI) case status. The study population included veterans from the Gulf War Era Cohort and Biorepository (n = 1116). Outcomes were physical and mental health from the Veterans RAND 12 and depression, post-traumatic stress (PTSD), sleep disturbance, and pain. Kansas (KS) and Centers for Disease Control and Prevention (CDC) GWI definitions were used. Kansas GWI derived subtypes included GWI (met symptom criteria; no exclusionary conditions (KS GWI: Sym+/Dx−)) and those without GWI: KS noncase (1): Sym+/Dx+, KS noncase (2): Sym−/Dx+, and noncase (3): Sym−/Dx−. CDC-derived subtypes included CDC GWI severe, CDC GWI mild-to-moderate and CDC noncases. Case status and outcomes were examined using multivariable regression adjusted for sociodemographic and military-related characteristics. Logistic regression analysis was used to examine associations between GWI case status and binary measures for depression, PTSD, and severe pain. The KS GWI: Sym+/Dx− and KS noncase (1): Sym+/Dx+ groups had worse mental and physical HRQOL outcomes than veterans in the KS noncase (2): Sym−/Dx+ and KS noncase (3): Sym−/Dx− groups (ps < 0.001). Individuals who met the CDC GWI severe criteria had worse mental and physical HRQOL outcomes than those meeting the CDC GWI mild-to-moderate or CDC noncases (ps < 0.001). For other outcomes, results followed a similar pattern. Relative to the less symptomatic comparison subtypes, veterans who met the Kansas symptom criteria, regardless of exclusionary conditions, and those who met the CDC GWI severe criteria experienced lower HRQOL and higher rates of depression, PTSD, and severe pain.
... At least 30% of Veterans who deployed to the Gulf War experience chronic and poorly understood physical symptoms across multiple systems including pain, fatigue and gastrointestinal distress [1]. Termed Gulf War Illness (GWI), Veterans with GWI experience significant disability and poor physical functioning [2,3]. ...
Article
Aims Gulf War Illness (GWI) is a prevalent and disabling condition characterized by persistent physical symptoms. Clinical practice guidelines recommend self-management to reduce the disability from GWI. This study evaluated which GWI self-management strategies patients currently utilize and view as most effective and ineffective. Materials and methods Data were collected from 267 Veterans during the baseline assessment of a randomized clinical trial for GWI. Respondents answered 3 open-ended questions regarding which self-management strategies they use, view as effective, and view as ineffective. Response themes were coded, and code frequencies were analyzed. Key findings Response frequencies varied across questions (in-use: n = 578; effective: n = 470; ineffective: n = 297). Healthcare use was the most commonly used management strategy (38.6% of 578), followed by lifestyle changes (28.5% of 578), positive coping (13% of 578), and avoidance (13.7% of 578). When asked about effective strategies, healthcare use (25.9% of 470), lifestyle change (35.7% of 470), and positive coping (17.4% of 470) were identified. Avoidance was frequently identified as ineffective (20.2% of 297 codes), as was invalidating experiences (14.1% of 297) and negative coping (10.4% of 297). Significance Patients with GWI use a variety of self-management strategies, many of which are consistent with clinical practice guidelines for treating GWI, including lifestyle change and non-pharmacological strategies. This suggests opportunities for providers to encourage effective self-management approaches that patients want to use.
... Symptoms of GWI remain persistent over time for the majority of affected veterans, with few experiencing improvement or recovery (Gwini et al., 2015;Hotopf et al., 2003;Ozakinci et al., 2006). Previous GWI research has sought to identify the epidemiology of GWI, the conditions in theater that may cause GWI, GWI-related nervous system dysfunctions, pathophysiological mechanisms underlying GWI, and experimental models of GWI and its causation (White et al., 2016). ...
Article
Background: Gulf War illness (GWI) is a condition that affects about 30% of veterans who served in the 1990-91 Persian Gulf War. Given its broad symptomatic manifestation, including chronic pain, fatigue, neurological, gastrointestinal, respiratory, and skin problems, it is of interest to examine whether GWI is associated with changes in the brain. Existing neuroimaging studies, however, have been limited by small sample sizes, inconsistent GWI diagnosis criteria, and potential comorbidity confounds. Objectives: Using a large cohort of US veterans with GWI, we assessed regional brain volumes for their associations with GWI, and quantified the relationships between any regional volumetric changes and GWI symptoms. Methods: Structural magnetic resonance imaging (MRI) scans from 111 veterans with GWI (Age = 49 ± 6, 88% Male) and 59 healthy controls (age = 51 ± 9, 78% male) were collected at the California War Related Illness and Injury Study Center (WRIISC-CA) and from a multicenter study of the Parkinson's Progression Marker Initiative (PPMI), respectively. Individual MRI volumes were segmented and parcellated using FreeSurfer. Regional volumes of 19 subcortical, 68 cortical, and 3 brainstem structures were evaluated in the GWI cohort relative to healthy controls. The relationships between regional volumes and GWI symptoms were also assessed. Results: We found significant subcortical atrophy, but no cortical differences, in the GWI group relative to controls, with the largest effect detected in the brainstem, followed by the ventral diencephalon and the thalamus. In a subsample of 58 veterans with GWI who completed the Chronic Fatigue Scale (CFS) inventory of Centers for Disease Control and Prevention (CDC), smaller brainstem volumes were significantly correlated with increased severities of fatigue and depressive symptoms. Conclusion: The findings suggest that brainstem volume may be selectively affected by GWI, and that the resulting atrophy could in turn mediate or moderate GWI-related symptoms such as fatigue and depression. Consequently, the brain stem should be carefully considered in future research focusing on GWI pathology.
Article
Gulf War Illness (GWI) is an unrelenting multi-symptom illness with chronic central nervous system and peripheral pathology affecting veterans from the 1991 Gulf War and for which effective treatment is lacking. An increasing number of studies indicate that persistent neuroinflammation is likely the underlying cause of cognitive and mood dysfunction that affects veterans with GWI. We have previously reported that fingolimod, a drug approved for the treatment of relapsing-remitting multiple sclerosis, decreases neuroinflammation and improves cognition in a mouse model of Alzheimer's disease. In this study, we investigated the effect of fingolimod treatment on cognition and neuroinflammation in a mouse model of GWI. We exposed C57BL/6J male mice to GWI-related chemicals pyridostigmine bromide, DEET, and permethrin, and to mild restraint stress for 28 days (GWI mice). Control mice were exposed to the chemicals' vehicle only. Starting 3 months post-exposure, half of the GWI mice and control mice were orally treated with fingolimod (1mg/kg/day) for 1 month, and the other half were left untreated. Decreased memory on the Morris water maze test was detected in GWI mice compared to control mice and was reversed by fingolimod treatment. Immunohistochemical analysis of brain sections with antibodies to Iba1 and GFAP revealed that GWI mice had increased microglia activation in the hippocampal dentate gyrus, but no difference in reactive astrocytes was detected. The increased activation of microglia in GWI mice was decreased to the level in control mice by treatment with fingolimod. No effect of fingolimod treatment on gliosis in control mice was detected. To explore the signaling pathways by which decreased memory and increased neuroinflammation in GWI may be protected by fingolimod, we investigated the involvement of the inflammatory signaling pathways of protein kinase R (PKR) in the cerebral cortex of these mice. We found increased phosphorylation of PKR in the brain of GWI mice compared to controls, as well as increased phosphorylation of its most recognized downstream effectors: the α subunit of eukaryotic initiation factor 2 (eIF2α), IκB kinase (IKK), and the p65 subunit of nuclear factor-κB (NFκB-p65). Furthermore, we found that the increased phosphorylation level of these three proteins were suppressed in GWI mice treated with fingolimod. These results suggest that activation of PKR and NFκB signaling may be important for the regulation of cognition and neuroinflammation in the GWI condition and that fingolimod, a drug already approved for human use, may be a potential candidate for the treatment of GWI.
Article
Objective: This study evaluated the factors that led to enrollment in, and satisfaction with, behavioral interventions for Veterans living with Gulf War Illness (GWI). Methods: One-on-one interviews were conducted pre- and post-intervention with participants randomized to receive either telephone delivered problem-solving treatment (n = 51) or health education (N = 49). A total of 99 Veterans were interviewed pre-intervention and 60 post-intervention. Qualitative data were thematically coded and similarities in themes across the two interventions were examined. Results: Before the study began, participants reported desiring to learn new information about their GWI, learn symptom-management strategies, and support improvements to care for other patients with GWI. After the intervention, Veterans felt positively about both interventions because they built strong therapeutic relationships with providers, their experiences were validated by providers, and they were provided GWI information and symptom-management strategies. Results also suggested that interventions do not have to be designed to meet all of the needs held by patients to be acceptable. A minority of participants described that they did not benefit from the interventions. Conclusion: The results suggest that satisfaction with behavioral interventions for GWI is driven by a strong therapeutic relationship, validating patient's experiences with GWI, and the intervention meeting some of the patient's needs, particularly increasing knowledge of GWI and improving symptom management.
Article
In a companion paper we examined whether combinations of Kv7 channel openers (Retigabine and Diclofenac; RET, DIC) could be effective modifiers of deep tissue nociceptor activity; and whether such combinations could then be optimized for use as safe analgesics for pain-like signs that developed in a rat model of GWI (Gulf War Illness) pain. In the present report, we examined the combinations of Retigabine/Meclofenamate (RET/MEC) and Meclofenamate/Diclofenac (MEC/DIC). Voltage clamp experiments were performed on deep tissue nociceptors isolated from rat DRG (dorsal root ganglion). In voltage clamp studies, a stepped voltage protocol was applied (-55 to -40 mV; Vh=-60 mV; 1500 msec) and Kv7 evoked currents were subsequently isolated by Linopirdine subtraction. MEC greatly enhanced voltage dependent conductance and produced exceptional maximum sustained currents of 6.01 ± 0.26 pA/pF (EC50: 62.2 ± 8.99 μM). Combinations of RET/MEC, and MEC/DIC substantially amplified resting currents at low concentrations. MEC/DIC also greatly improved voltage dependent conductance. In current clamp experiments, a cholinergic challenge test (Oxotremorine-M, 10 μM; OXO), associated with our GWI rat model, produced powerful action potential (AP) bursts (85 APs). Optimized combinations of RET/MEC (5 and 0.5 μM) and MEC/DIC (0.5 and 2.5 μM) significantly reduced AP discharges to 3 and 7 Aps, respectively. Treatment of pain-like ambulatory behavior in our rat model with a RET/MEC combination (5 and 0.5 mg/kg) successfully rescued ambulation deficits, but could not be fully separated from the effect of RET alone. Further development of this approach is recommended.
Article
Full-text available
Objective: This analysis examined the relationship between GW exposures and health symptoms reported in three time periods over 20 years in Ft. Devens Cohort veterans. Methods: Repeated logistic regression models examined the association of exposures and health symptoms over time. Models included baseline age, active duty status, PTSD status, sex, and time since deployment as covariates. Results: Exposure to tent heaters was associated with increased odds of crying easily and muscle twitching. Exposure to PB pills was associated with increased odds of depression and fatigue. Exposure to the Khamisiyah sarin plume was associated with increased odds of trouble concentrating and crying easily. Conclusions: This longitudinal analysis demonstrated an association between neurotoxicant exposures and increased odds of cognitive/mood, fatigue, and neurological symptoms. Additionally, most symptoms increased over time since deployment regardless of exposure.
Chapter
In the context of development, the informal sector assumes importance owing to its large workforce; all the more so, because it is a major site of exclusion. A study of this sector has, therefore, become essential from the standpoint of the mainstream strategy of inclusive growth. It is opined by the dominant discourse that a major part of this informal sector could, in fact, act as dynamic micro-capital and thereby, could engender an inclusive growth process. In this context, we have tried to understand, whether the informal firms have the potential to survive and grow as micro-capital or they are just subsisting and even decaying as non-capitalistic petty firms, using quantitative as also qualitative information collected through primary surveys, focus group discussions and individual interviews on a variety of unorganised/informal manufacturing units engaged in iron forging and fabrication and in handloom weaving. We have tried to understand these tendencies focusing on various aspects like production organisation, especially owner–labourer relation, market structure, especially hierarchies and bottlenecks and on abilities/intensions of the firms to survive/grow. We have also considered certain firm-characteristics as well as socio-economic-cultural features of the surveyed locations to analyse how firm behaviours (as micro-capital or non-capital) are influenced by these firm-traits and environment. Summarising our results and engaging with the literature, we could say that, although, a few firms may be behaving like dynamic micro-capital (Bardhan in Econ Polit Wkly 44:31–36, 2009; Marjit and Kar in The outsiders: economic reform and informal labour in a developing economy, Oxford University Press, New Delhi, 2011) having symptoms of progression and some control over markets, overwhelming majority, without much of owner–worker separation and almost no control over markets, is able and/or interested in maintaining their existence only (Sanyal in Rethinking capitalist development: primitive accumulation, governmentality and post-colonial capitalism, Routledge, New Delhi, 2007; Chatterjee in Econ Polit Wkly 19:53–62, 2008).
Article
Full-text available
A 36-item short-form (SF-36) was constructed to survey health status in the Medical Outcomes Study. The SF-36 was designed for use in clinical practice and research, health policy evaluations, and general population surveys. The SF-36 includes one multi-item scale that assesses eight health concepts: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions. The survey was constructed for self-administration by persons 14 years of age and older, and for administration by a trained interviewer in person or by telephone. The history of the development of the SF-36, the origin of specific items, and the logic underlying their selection are summarized. The content and features of the SF-36 are compared with the 20-item Medical Outcomes Study short-form.
Article
Full-text available
A 36-item short-form (SF-36) was constructed to survey health status in the Medical Outcomes Study. The SF-36 was designed for use in clinical practice and research, health policy evaluations, and general population surveys. The SF-36 includes one multi-item scale that assesses eight health concepts: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions. The survey was constructed for self-administration by persons 14 years of age and older, and for administration by a trained interviewer in person or by telephone. The history of the development of the SF-36, the origin of specific items, and the logic underlying their selection are summarized. The content and features of the SF-36 are compared with the 20-item Medical Outcomes Study short-form.
Article
A simple answer is found for the following question which has plagued the practice of the analysis of variance: Under the usual assumptions, if the conventional.F-test of the hypothesis H: μ1=μ2=…=μk at the α level of significance rejects H, what further inferences are valid about the contrasts among the μi (beyond the inference that the values of the contrasts are not all zero)? Suppose the F-test has k−1 and v degrees of freedom. For any c1, …, ck with ∑1kci=0 write θ for the contrast ∑1kciμi,⁠, and write ^θ and σ^θ^2 for the usual estimates of θ and the variance of ^θ⁠. Then for the totality of contrasts, no matter what the true values of the θ's, the probability is 1−α that they all satisfy θ^-Sσ^θ^≤θ≤θ^+Sσ^θ^, where S² is (k−1) times the upper α point of the F-distribution with k−1 and v degrees of freedom. Suppose we say that the estimated contrast with ^θ is ‘significantly different from zero’ if |^θ > S^σ^θ. Then the F-test rejects H if and only if some ^θ are significantly different from zero, and if it does, we can say just which ^θ⁠. More generally, the above inequality can be employed for all the contrasts with the obvious frequency interpretation about the proportion of experiments in which all statements are correct. Relations are considered to an earlier method of Tukey using the Studentized range tables and valid in the special case where the ^μi all have the same variance and all pairs ^μi, ^μj (i≠j) have the same covariance. Some results are obtained for the operating characteristic of the new method. The paper is organized so that the reader who wishes to learn the method and avoid the proofs may skip §§ 2 and 5
Article
The widespread use of standardized health surveys is predicated on the largely untested assumption that scales constructed from those surveys will satisfy minimum psychometric requirements across diverse population groups. Data from the Medical Outcomes Study (MOS) were used to evaluate data completeness and quality, test scaling assumptions, and estimate internal-consistency reliability for the eight scales constructed from the MOS SF-36 Health Survey. Analyses were conducted among 3,445 patients and were replicated across 24 subgroups differing in sociodemographic characteristics, diagnosis, and disease severity. For each scale, item-completion rates were high across all groups (88% to 95%), but tended to be somewhat lower among the elderly, those with less than a high school education, and those in poverty. On average, surveys were complete enough to compute scales scores for more than 96% of the sample. Across patient groups, all scales passed tests for item-internal consistency (97% passed) and item-discriminant validity (92% passed). Reliability coefficients ranged from a low of 0.65 to a high of 0.94 across scales (median = 0.85) and varied somewhat across patient subgroups. Floor effects were negligible except for the two role disability scales. Noteworthy ceiling effects were observed for both role disability scales and the social functioning scale. These findings support the use of the SF-36 survey across the diverse populations studied and identify population groups in which use of standardized health status measures may or may not be problematic.
Article
Cross-sectional data from the Medical Outcomes Study (MOS) were analyzed to test the validity of the MOS 36-Item Short-Form Health Survey (SF-36) scales as measures of physical and mental health constructs. Results from traditional psychometric and clinical tests of validity were compared. Principal components analysis was used to test for hypothesized physical and mental health dimensions. For purposes of clinical tests of validity, clinical criteria defined mutually exclusive adult patient groups differing in severity of medical and psychiatric conditions. Scales shown in the components analysis to primarily measure physical health (physical functioning and role limitations-physical) best distinguished groups differing in severity of chronic medical condition and had the most pure physical health interpretation. Scales shown to primarily measure mental health (mental health and role limitations-emotional) best distinguished groups differing in the presence and severity of psychiatric disorders and had the most pure mental health interpretation. The social functioning, vitality, and general health perceptions scales measured both physical and mental health components and, thus, had the most complex interpretation. These results are useful in establishing guidelines for the interpretation of each scale and in documenting the size of differences between clinical groups that should be considered very large.
Article
A self-rating scale was developed to measure the severity of fatigue. Two-hundred and seventy-four new registrations on a general practice list completed a 14-item fatigue scale. In addition, 100 consecutive attenders to a general practice completed the fatigue scale and the fatigue item of the revised Clinical Interview Schedule (CIS-R). These were compared by the application of Relative Operating Characteristic (ROC) analysis. Tests of internal consistency and principal components analyses were performed on both sets of data. The scale was found to be both reliable and valid. There was a high degree of internal consistency, and the principal components analysis supported the notion of a two-factor solution (physical and mental fatigue). The validation coefficients for the fatigue scale, using an arbitrary cut off score of 3/4 and the item on the CIS-R were: sensitivity 75.5 and specificity 74.5.
Article
Since the 1990-1991 Persian Gulf War, there has been persistent concern that U.S. war veterans may have had adverse health consequences, including higher-than-normal mortality. We conducted a retrospective cohort study of postwar mortality according to cause among 695,516 Gulf War veterans and 746,291 other veterans. The follow-up continued through September 1993. A stratified, multivariate analysis (with Cox proportional-hazards models) controlled for branch of service, type of unit, age, sex, and race in comparing the two groups. We used standardized mortality ratios to compare the groups of veterans with the general population of the United States. Among the Gulf War veterans, there was a small but significant excess of deaths as compared with the veterans who did not serve in the Persian Gulf (adjusted rate ratio, 1.09; 95 percent confidence interval, 1.01 to 1.16). The excess deaths were mainly caused by accidents (1.25; 1.13 to 1.39) rather than disease (0.88; 0.77 to 1.02). The corresponding rate ratios among 49,919 female veterans of the Gulf War were 1.32 (0.95 to 1.83) for death from all causes, 1.83 (1.02 to 3.28) for accidental death, and 0.89 (0.45 to 1.78) for death from disease. In both groups of veterans the mortality rates were significantly lower overall than those in the general population. The adjusted standardized mortality ratios were 0.44 (95 percent confidence interval, 0.42 to 0.47) for Gulf War veterans and 0.38 (0.36 to 0.40) for other veterans. Among veterans of the Persian Gulf War, there was a significantly higher mortality rate than among veterans deployed elsewhere, but most of the increase was due to accidents rather than disease, a finding consistent with patterns of postwar mortality among veterans of previous wars.